Krsnaa Diagnostics Limited (BOM:543328)
India · Delayed Price · Currency is INR 535.40
+3.50 (0.66%)
At close: Jun 12, 2026
Krsnaa Diagnostics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 7,728 | 7,172 | 6,196 | 4,871 | 4,555 |
Other Revenue | 259.52 | - | - | - | - |
| 7,987 | 7,172 | 6,196 | 4,871 | 4,555 | |
Revenue Growth (YoY) | 11.37% | 15.74% | 27.20% | 6.95% | 14.88% |
Cost of Revenue | 1,790 | 1,727 | 1,513 | 899.54 | 755.7 |
Gross Profit | 6,197 | 5,445 | 4,683 | 3,972 | 3,799 |
Selling, General & Admin | 2,022 | 2,046 | 1,888 | 1,680 | 1,724 |
Other Operating Expenses | 1,797 | 1,498 | 1,353 | 1,062 | 757.77 |
Operating Expenses | 4,723 | 4,427 | 3,987 | 3,279 | 2,895 |
Operating Income | 1,474 | 1,018 | 696.44 | 692.39 | 903.37 |
Interest Expense | -343.64 | -217.58 | -140.87 | -64.35 | -168.63 |
Interest & Investment Income | - | 167 | 167.6 | 181.24 | 149.09 |
Earnings From Equity Investments | -0.69 | - | - | - | - |
Other Non Operating Income (Expenses) | 174.38 | 12.96 | -23.67 | -9.03 | -16.27 |
EBT Excluding Unusual Items | 1,304 | 980.03 | 699.5 | 800.25 | 867.56 |
Gain (Loss) on Sale of Assets | - | 46.84 | 0.57 | 1.76 | -2.48 |
Pretax Income | 1,304 | 1,027 | 700.07 | 802.01 | 865.08 |
Income Tax Expense | 289.36 | 250.79 | 131.7 | 180.9 | 181.2 |
Net Income | 1,014 | 776.08 | 568.37 | 621.11 | 683.88 |
Net Income to Common | 1,014 | 776.08 | 568.37 | 621.11 | 683.88 |
Net Income Growth | 30.70% | 36.55% | -8.49% | -9.18% | -63.02% |
Shares Outstanding (Basic) | 32 | 32 | 32 | 31 | 30 |
Shares Outstanding (Diluted) | 33 | 33 | 33 | 32 | 30 |
Shares Change (YoY) | -0.30% | 0.33% | 1.99% | 7.74% | 16.13% |
EPS (Basic) | 31.30 | 24.03 | 17.90 | 19.78 | 22.89 |
EPS (Diluted) | 30.88 | 23.56 | 17.31 | 19.29 | 22.88 |
EPS Growth | 31.07% | 36.11% | -10.26% | -15.69% | 86.72% |
Free Cash Flow | -761.61 | -393 | -1,695 | -650.59 | -37.95 |
Free Cash Flow Per Share | -23.19 | -11.93 | -51.63 | -20.21 | -1.27 |
Dividend Per Share | 2.000 | 2.750 | 2.500 | 2.750 | 2.500 |
Dividend Growth | -27.27% | 10.00% | -9.09% | 10.00% | - |
Gross Margin | 77.58% | 75.92% | 75.58% | 81.53% | 83.41% |
Operating Margin | 18.45% | 14.19% | 11.24% | 14.21% | 19.84% |
Profit Margin | 12.70% | 10.82% | 9.17% | 12.75% | 15.02% |
Free Cash Flow Margin | -9.54% | -5.48% | -27.36% | -13.36% | -0.83% |
EBITDA | 2,378 | 1,799 | 1,365 | 1,220 | 1,312 |
EBITDA Margin | 29.78% | 25.08% | 22.02% | 25.04% | 28.81% |
D&A For EBITDA | 904.61 | 780.99 | 668.07 | 527.33 | 408.85 |
EBIT | 1,474 | 1,018 | 696.44 | 692.39 | 903.37 |
EBIT Margin | 18.45% | 14.19% | 11.24% | 14.21% | 19.84% |
Effective Tax Rate | 22.20% | 24.42% | 18.81% | 22.56% | 20.95% |
Revenue as Reported | 8,162 | 7,427 | 6,364 | 5,065 | 4,704 |
Advertising Expenses | - | 19.81 | 29.36 | 31.91 | 18.09 |